在双盲,随机,交叉的人体试验中,新型的菌素配方的西利玛林 (乳) 具有增强的生物利用性
Chuck Chang1, Yiming Zhang1, Yun Chai Kuo1
1ISURA, Burnaby, BC V3N4S9, Canada.
Pharmaceutics
|July 30, 2025
概括
一种新的小乳配方显著提高了西利马林的生物可用性,显示出18.9倍的Cmax和更快的吸收. 这种增强的乳 (Silybum marianum) 输送可能会改善肝脏健康的临床疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 营养学科学 营养学科学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 乳 (Silybum marianum) 中的活性化合物西利马林具有已知的肝保护作用.
- 溶解性较差和广泛的第一通代谢限制了西利玛林口服生物可用性.
- 需要新的配方策略来增强西利马林的吸收和疗效.
研究的目的:
- 为了评估一种新的小牛乳配方的药理动力学和耐受性.
- 为了比较从微粒配方中吸收的西利马林与标准的乳产品的吸收.
- 在健康参与者中评估增强配方的安全性.
主要方法:
- 一项随机,双盲,交叉研究,涉及16名健康参与者.
- 一次剂量小 (LMM) 或标准 (STD) 乳 (130毫克西利玛林).
- 在24小时内测量血中的西利马林度,以确定药理动力学参数 (Cmax,Tmax,AUC).
主要成果:
- 与标准配方相比,微粒配方的Cmax高出18.9倍,AUC0-24高出11.4倍.
- 观察到细胞配方的吸收速度更快,Tmax显著缩短 (0.5小时对2.5小时).
- 对于这两种配方,没有报告任何重大不良事件或安全问题.
结论:
- 这种新型的菌乳配方表明,它显著提高了西利马林的生物可用性和吸收动力学.
- 改善的药理动力学特征表明,在支持肝脏健康方面,临床疗效可能会增加.
- 该配方耐受性良好,这表明西利玛林输送的安全性概况有利.
关键词:
脂质烯 (LipoMicel) 是一种有机化学物质.生物可用性 生物可用性肝脏保护性 肝脏保护性人类研究研究人类研究.肝脏健康 肝脏健康迈塞尔斯 (Micelles) 是一个非常有价值的人.牛奶的牛奶是什么意思药物动力学 药物动力学西利玛林是一种制剂.更多相关视频
相关概念视频
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:16Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...